Dr. Katherine Bever

Behind the Study: Metformin and Rapamycin as Maintenance Therapy

Dr. Katherine Bever from Johns Hopkins University discusses a research paper she co-authored that was published by Oncotarget, “An exploratory study of metformin with or without rapamycin as maintenance therapy after… read more
Dr. Jennifer Sheng

Testimonial: Dr. Jennifer Sheng

Dr. Jennifer Sheng from Johns Hopkins Sidney Kimmel Comprehensive Cancer Center shares her experience publishing "Innovating and expanding weight loss strategies for breast cancer survivors" with Oncotarget. Listen to an audio… read more
Dr. Gina Abdelaal

Testimonial: Dr. Gina Abdelaal

Dr. Gina Abdelaal from Northumbria University discusses her experience publishing “Reversing oncogenic transformation with iron chelation,” with Oncotarget. Listen to an audio version of this post Dr. Gina Abdelaal I selected Oncotarget because… read more
Dr. Monica Varun Tyagi

Testimonial: Dr. Monica Varun Tyagi

Dr. Monica Varun Tyagi discusses her experience publishing “GATA3 and APOBEC3B are prognostic markers in adrenocortical carcinoma and APOBEC3B is directly transcriptionally regulated by GATA3,” with Oncotarget. Listen to an audio… read more
Dr. Michael Roehrl

Testimonial: Dr. Michael Roehrl

Dr. Michael Roehrl from the Department of Pathology, Memorial Sloan Kettering Cancer Center discusses his experience while publishing the paper, “Prolyl 4-hydroxylase alpha 1 protein expression risk-stratifies early stage colorectal… read more
Dr. Michael Andreeff

Testimonial: Dr. Michael Andreeff

Below is a transcript of the testimonial by Dr. Michael Andreeff, from the University of Texas MD Anderson Cancer Center, about his experience publishing the paper, “Tumor Trp53 status and genotype affect the bone marrow… read more
Dr. Ken Pienta

Testimonial: Dr. Ken Pienta

Below is the transcript of a testimonial by Dr. Ken Pienta from Johns Hopkins School of Medicine on his experiences publishing numerous research papers with Oncotarget. — Listen to an audio version of this post… read more